High Total Cholesterol in Primary Biliary Cholangitis cases tied to poor clinical outcomes
Written By : Aditi
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2024-02-21 22:00 GMT | Update On 2024-02-21 22:01 GMT
Advertisement
Patients with primary biliary cholangitis (PBC) often have hypercholesterolemia. However, its association with prognosis and lipid metabolism remains unclear.
Researchers have conducted a study aimed to investigate the prognostic value of baseline total cholesterol (TC) levels in PBC and characterized the lipid metabolism.
The study published in Clinical Gastroenterology and Hepatology has concluded that Primary biliary cholangitis patients with baseline total cholesterol levels above 5.2 mmol/L have unique lipidome characteristics. These patients are at greater risk of poor clinical outcomes.
This study investigated the prognostic value of baseline total cholesterol (TC) levels in PBC and characterize lipid metabolism.
The 531 PBC patients with no history of prior cirrhosis-related complications were divided into the derivation and validation cohorts (ratio of 7:3). Their complete clinical data were analyzed, with liver-related death, liver transplantation, and cirrhosis-related complications as endpoints. Untargeted lipidomics were performed on 89 patients and 28 healthy controls or HC.
Key findings from the study are:
- Baseline total cholesterol (TC) levels were independently associated with poor clinical outcomes, as demonstrated by adjusted C-statistics of 0.8035 and 0.8754 in the derivation and validation cohorts, respectively.
- The 5.2 mmol/L cut-off optimally divided patients into low- and high-risk groups.
- In low total cholesterol patients whose baseline total cholesterol level was < 200 mg/dL, the metabolism was similar to healthy controls.
- In high total cholesterol patients with a baseline total cholesterol level of more than 200 mg/dL, there was upregulated glycerophospholipid and sphingolipid metabolism.
According to our findings, they said individuals with primary biliary cholangitis (PBC) and baseline total cholesterol (TC) levels higher than 5.2 mmol/L exhibit distinct lipidome features and face an increased likelihood of unfavourable clinical results.The combination of total cholesterol and Globe score may provide a more accurate risk stratification of patients with PBC.
Reference:
Zheng et al. Hypercholesterolemia is associated with dysregulation of lipid metabolism and poor prognosis in primary biliary cholangitis. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2024.01.039
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.